Repligen Corp financial data

Symbol
RGEN on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
41 Seyon Street, Building 1, Suite 100, Waltham, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 18, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 720 % +186%
Quick Ratio 123 % +109%
Debt-to-equity 43.5 % +41.3%
Return On Equity -0.41 % -108%
Return On Assets -0.28 % -107%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 56M shares +0.35%
Common Stock, Shares, Outstanding 56M shares +0.45%
Entity Public Float 6.93B USD -22.2%
Common Stock, Value, Issued 560K USD +0.36%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 41.8M USD -4%
Costs and Expenses 622M USD +9.97%
Operating Income (Loss) 11.3M USD -87%
Nonoperating Income (Expense) 2.18M USD -89.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 13.4M USD -87.5%
Income Tax Expense (Benefit) 21.5M USD +205%
Net Income (Loss) Attributable to Parent -8.1M USD -108%
Earnings Per Share, Basic -0.15 USD/shares -108%
Earnings Per Share, Diluted -0.14 USD/shares -108%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 784M USD +24.3%
Accounts Receivable, after Allowance for Credit Loss, Current 129M USD +21.5%
Inventory, Net 182M USD -13.7%
Other Assets, Current 13.3M USD +29.6%
Assets, Current 1.13B USD +15.4%
Deferred Income Tax Assets, Net 101K USD -93.5%
Property, Plant and Equipment, Net 203M USD +0.48%
Operating Lease, Right-of-Use Asset 127M USD +7.78%
Intangible Assets, Net (Excluding Goodwill) 381M USD +8.69%
Goodwill 988M USD +13.6%
Other Assets, Noncurrent 748K USD -48.2%
Assets 2.83B USD +12.2%
Accounts Payable, Current 21.4M USD +12.6%
Employee-related Liabilities, Current 28.1M USD +105%
Accrued Liabilities, Current 60.9M USD +4.79%
Liabilities, Current 108M USD -71.4%
Operating Lease, Liability, Noncurrent 139M USD +6.19%
Other Liabilities, Noncurrent 11.6M USD +4.05%
Liabilities 814M USD +48.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -34.6M USD +20.2%
Retained Earnings (Accumulated Deficit) 441M USD -1.8%
Stockholders' Equity Attributable to Parent 2.02B USD +2.18%
Liabilities and Equity 2.83B USD +12.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 44.7M USD +301%
Net Cash Provided by (Used in) Financing Activities -8.97M USD +6.16%
Net Cash Provided by (Used in) Investing Activities -8.36M USD +11.4%
Common Stock, Shares Authorized 80M shares 0%
Common Stock, Shares, Issued 56M shares +0.45%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 29.3M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 784M USD +24.3%
Deferred Tax Assets, Valuation Allowance 20K USD +5.26%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 83.8M USD +18.9%
Operating Lease, Liability 159M USD +15%
Depreciation 23.9M USD +45.7%
Payments to Acquire Property, Plant, and Equipment 8.35M USD -1.92%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 648K USD -99.4%
Lessee, Operating Lease, Liability, to be Paid 201M USD +10%
Property, Plant and Equipment, Gross 356M USD +10.7%
Operating Lease, Liability, Current 12.2M USD +267%
Lessee, Operating Lease, Liability, to be Paid, Year Two 25.6M USD +18.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 22.6M USD +13.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) -1.12M USD -42.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 32.6M USD +9.17%
Lessee, Operating Lease, Liability, to be Paid, Year Three 25.4M USD +17.8%
Deferred Tax Assets, Operating Loss Carryforwards 7.65M USD -22%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 3.14M USD +4.77%
Lessee, Operating Lease, Liability, to be Paid, Year Four 23.9M USD +12.1%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 34.9M USD +16.3%
Deferred Tax Assets, Net of Valuation Allowance 83.8M USD +18.9%
Interest Expense 11.3M USD +887%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%